Crescent Biopharma, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2012 | $15.3M | $3.6M | $3.7M |
| FY2013 | $4.0M | $-10.6M | $-10.6M |
| FY2014 | $15.0M | $-11.1M | $-11.1M |
| FY2015 | $20.1M | $-12.8M | $-12.8M |
| FY2016 | $18.5K | $-31.9M | $-31.8M |
| FY2017 | — | $-33.9M | $-33.3M |
| FY2018 | — | $-51.5M | $-48.3M |
| FY2019 | — | $-61.4M | $-57.9M |
| FY2020 | $10.2M | $-51.5M | $-51.0M |
| FY2021 | $1.2M | $-63.4M | $-63.4M |
| FY2022 | $75.0K | $-47.4M | $-46.7M |
| FY2023 | $10.0K | $-39.3M | $-36.9M |
| FY2024 | — | $-40.0M | $-37.9M |
| FY2025 | $10.8M | $-152.6M | $-153.9M |